The Baldwin Group (BWIN) Q1 2026 earnings review
Acquisition Fuels Top-Line Boom, But Dilution Crushes Earnings Growth
Baldwin delivered a massive 29% surge in Q1 revenue to $532.2 million, entirely fueled by the January closing of the CAC Group partnership. However, the cost of this growth is staggering. Beneath the optical top-line acceleration, core profitability is decelerating. Adjusted EPS actually fell 3% YoY to $0.63 as a 40% jump in share count and a 31% spike in interest expense erased all $137.2 million of Adjusted EBITDA. Furthermore, reported organic growth collapsed to just 2%. While management points to a 'normalized' 9% organic growth figure, the massive gap suggests underlying friction in the legacy business. The integration is moving fast, but investors are paying a steep price in near-term dilution and negative cash flow.
🐂 Bull Case
The CAC Group integration is materially ahead of schedule. Management claims 80% of targeted 3-year expense synergies are already actioned, with revenue cross-sell wins materializing faster than anticipated.
Management states that 'normalized' organic growth, inclusive of the new January partnerships, is running at 9%. They are guiding to exit 2026 at a double-digit organic growth run rate.
🐻 Bear Case
Despite a 21% jump in Adjusted EBITDA, Adjusted EPS dropped 3%. The share count skyrocketed from 69.3M to 96.8M, proving the CAC deal was highly dilutive in the near term.
Adjusted free cash flow reversed from positive $25.8M in 25Q1 to negative $0.2M this quarter, heavily pressuring the company's ability to organically deleverage or execute its previously touted $250M share buyback.
⚖️ Verdict: ⚪
Neutral. The CAC Group deal successfully transformed Baldwin into a larger platform, but the aggressive debt and equity issuance means the business must execute flawlessly. Shrinking EPS and evaporating cash flow limit their margin of error.
Key Themes
CAC Group Integration Yielding Early Results
The massive 29% revenue jump was heavily concentrated in the January partnerships, led by CAC Group. Management confirmed that integration is meaningfully ahead of plan with 80% of expense synergies actioned. This is a critical driver for reversing the margin compression seen this quarter.
Reported Organic Growth Collapses
Management claims 'accelerating earnings power,' yet the reported data contradicts this: official organic growth decelerated sharply to just 2% from 10% a year ago. Even though management provides a 'normalized' 9% figure, the massive 700 bps gap indicates that either legacy business lines are dragging significantly, or the methodology for excluding divestitures and first-12-month M&A revenue is masking underlying churn.
M&A Dilution Outpaces EBITDA Growth
Decelerating/Reversing. Baldwin delivered an impressive 21% growth in Adjusted EBITDA ($137.2M). However, this failed to reach the bottom line. Weighted average diluted shares surged 40% (to 96.8M) and interest expense climbed 31% to $38.9M. This capital structure burden caused Adjusted EPS to shrink 3% YoY, completely neutralizing the operational gains of the acquisition.
AI & The $3B/30 Catalyst Program
Management continues to advance its '$3B/30 Catalyst' transformation program. In response to macro concerns regarding AI disintermediation, Baldwin is explicitly infusing artificial intelligence and business process optimization into its workforce to elevate the platform. Transformation costs associated with this program hit $3.0M in the quarter (up from $0.5M a year ago), representing near-term pain for long-term margin defense.
Free Cash Flow Turns Negative
Reversing. Adjusted free cash flow dropped from positive $25.8 million in 25Q1 to negative $0.2 million in 26Q1. Combined with an operating cash flow drain of $6.1 million (driven by higher assumed premiums and receivables), working capital needs are starving the company of cash. This severely complicates the aggressive $250M share repurchase narrative established in the Q4 call.
Other KPIs
Decelerating. Down 170 basis points from 27.5% in the prior-year period. This indicates near-term negative operating leverage as the company absorbs the cost structure of the CAC Group before full revenue and back-office synergies can be realized.
Accelerating. Up 30% from $30.0M a year ago. The expanded debt load to fund aggressive M&A is putting a hard ceiling on net income generation, turning a $101.3M operating loss into a pre-tax hole.
Exploding upward. Total earnout liabilities (current + long-term) spiked from $23.3M at the end of 2025 to over $335.4M in 26Q1. This massive future cash obligation limits balance sheet flexibility over the coming years.
Guidance
Accelerating. Management maintained their qualitative guidance to exit 2026 on a double-digit organic growth run rate. Given the Q1 reported organic growth of just 2%, this implies a massive sequential ramp must occur over the next three quarters.
Accelerating. While not explicitly updated in the Q1 print, the previously guided midpoint of $2.03B implies roughly 35% full-year growth over FY25's $1.5B. Q1's $532M print puts them well on track (accounting for roughly 26% of the annual target in Q1 alone).
Key Questions
The Organic Growth Gap
There is a massive 700 basis point spread between your reported 2% organic growth and your 9% 'normalized' figure. Specifically, which legacy segments are dragging down the reported metric, and why?
Share Repurchase Viability
In the Q4 call, management stated 'at 8x EBITDA, there is not a better use of capital than buying our own shares.' With Q1 adjusted free cash flow turning negative, what is the realistic timeline and funding mechanism for executing the $250M repurchase authorization?
Margin Expansion Timeline
Adjusted EBITDA margins compressed by 170 bps YoY to 25.8%. If 80% of CAC expense synergies are already actioned, when will we see margins inflect positively toward your 30% long-term target?
Earnout Obligations
Contingent earnout liabilities surged to over $335M this quarter. Can you outline the cash outflow schedule for these obligations over the next 12-24 months and how it impacts your deleveraging targets?